Mutant huntingtin fails to directly impair brain mitochondria

James Hamilton1, Tatiana Brustovetsky1, Nickolay Brustovetsky1,2

  • 1Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Insights

Mutant huntingtin (mHtt) does not directly damage mitochondria in Huntington's disease (HD). Studies show that even when mHtt binds to mitochondria, key functions like respiration and membrane potential remain unaffected, refuting a direct damaging mechanism.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Huntington's disease (HD) pathogenesis is linked to mutant huntingtin (mHtt).
  • mHtt-induced mitochondrial dysfunction is a proposed mechanism in HD.
  • The precise role of mHtt in mitochondrial damage remains unclear.

Purpose of the Study:

  • To investigate whether mutant huntingtin (mHtt) directly damages mitochondria.
  • To test the hypothesis that mHtt directly impairs mitochondrial function in Huntington's disease.

Main Methods:

  • Incubation of wild-type and YAC128 mouse brain mitochondria with mHtt-containing cytosolic fractions.
  • Assessment of mitochondrial respiration, membrane potential, Ca2+ uptake, and reactive oxygen species production.
  • Quantification of mHtt binding to isolated mitochondria.

Main Results:

  • Mutant huntingtin (mHtt) bound to wild-type and YAC128 mouse brain mitochondria.
  • No significant alterations in mitochondrial respiration, membrane potential, Ca2+ uptake, or ROS production were observed.
  • Enrichment of YAC128 brain mitochondria with mHtt did not induce functional deficits.

Conclusions:

  • Mutant huntingtin (mHtt) does not appear to directly impair mitochondrial function.
  • The direct mitochondrial damage mechanism is unlikely to be involved in Huntington's disease pathogenesis.
  • Findings challenge the role of direct mHtt-mitochondria interaction in HD progression.

Related Concept Videos

Peroxisomes and Mitochondria01:30

Peroxisomes and Mitochondria

Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
94.4K
Hypothesis: Accept or Fail to Reject?01:17

Hypothesis: Accept or Fail to Reject?

The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
29.3K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.6K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
12.4K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
433
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
259